文献速递临床生化临床免疫

分析准确但临床不准:假性甲状旁腺功能亢进症的诊断案例

Analytically accurate, clinically inaccurate: A diagnostic case of Pseudohyperparathyroidism.
PubMed 文献 · Clin Chim Acta · 2026-08-11

本文报告一例33岁肾移植受者,既往因继发性甲状旁腺功能亢进接受甲状旁腺切除术,本次就诊时PTH浓度异常升高超过分析测量范围(AMR),而血清钙磷正常。通过系列稀释、PEG沉淀和异嗜性抗体阻断研究排除免疫分析干扰后,最终证实PTH升高呈采集部位依赖性,而非真正的系统性过度分泌,提示分析有效性不等于临床有效性。

要点

  • PTH结果异常升高但钙磷正常时,应警惕分析前因素而非直接诊断甲状旁腺功能亢进。
  • 系列稀释、PEG沉淀和异嗜性抗体阻断可用于排除免疫分析干扰。
  • 采集部位不同可导致PTH结果差异,尤其在有甲状旁腺自体移植和血管通路受限者中。

核心结论

  • 分析有效性不总是等同于临床有效性,标本采集部位可影响PTH结果解读。
  • 临床与实验室紧密合作对识别分析前来源的不一致结果并避免误判至关重要。

研究设计与样本

  • 单例诊断案例报告:33岁肾移植受者,既往因继发性甲状旁腺功能亢进接受甲状旁腺切除术。

主要发现

  • PTH浓度异常升高超过分析测量范围(AMR),而血清钙和磷正常。
  • 系列稀释研究显示线性比例回收,符合阴性对照。
  • PEG沉淀和异嗜性抗体阻断研究未能将PTH降至AMR内,使显著免疫分析干扰可能性不大。
  • 最终证实PTH升高呈采集部位依赖性,而非真正系统性过度分泌,经替代部位重复采样确认。

临床怎么用

  • 当PTH结果与钙磷等生化指标明显不一致时,应系统排查分析前因素包括采集部位。
  • 对既往甲状旁腺自体移植和血管通路受限患者,解读PTH时应考虑采集部位的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Laboratory results are central to the diagnosis and management of endocrine disorders, but preanalytical factors may lead to misleading findings and inappropriate clinical interpretation. We report a 33-year-old kidney transplant recipient with a history of secondary hyperparathyroidism treated by parathyroidectomy several years earlier, who presented with an unexpectedly elevated parathyroid hormone (PTH) concentration exceeding the analytical measurement range (AMR) despite normal serum calcium and phosphorus. Given the marked biochemical discordance, a structured investigation was undertaken to exclude assay-related causes. Serial dilution studies demonstrated linear, proportional recovery consistent with negative controls. Polyethylene glycol (PEG) precipitation and heterophile antibody blocking studies failed to reduce PTH into the AMR, making significant immunoassay interference unlikely. With analytical causes excluded, investigation focused on preanalytical variables and ultimately demonstrated a collection-site-dependent elevation in PTH rather than true systemic hypersecretion, confirmed on repeat sampling from an alternative site. This finding was particularly relevant in the context of prior parathyroid autotransplantation and limited vascular access. This case highlights that analytical validity does not always equate to clinical validity and underscores the importance of specimen collection site in the interpretation of PTH results. Close collaboration between clinicians and the clinical laboratory is essential to recognize preanalytical sources of discordant results and avoid misinterpretation.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Swartchick CB, Boysen JL, Pearce RW, et al. Analytically accurate, clinically inaccurate: A diagnostic case of Pseudohyperparathyroidism. Clin Chim Acta. 2026. PMID: 42580610. doi:10.1016/j.cca.2026.121274

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。